Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VALEANT PHARMACEUTICALS INTL INC T.VRX

Healthcare Drug Manufacturers - Specialty & Generic
"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

VALEANT PHARMACEUTICALS INTL INC > Wow , Paulson &Eco buying VRX to 12.5%
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(30)
•••
Comment by domcolumbaon Aug 16, 2017 11:59am
105 Views
Post# 26587770

RE:RE:RE:RE:RE:Wow , Paulson &Eco buying VRX to 12.5%

RE:RE:RE:RE:RE:Wow , Paulson &Eco buying VRX to 12.5%

Aug 14, 2017

BRIEF-Paulson & Co dissolves share stake in Pfizer, ups in Valeant ‍

5:12PM ET on Monday Aug 14, 2017 by Thomson Reuters
 

Aug 14 (Reuters) - Paulson & Co Inc :

* Paulson & Co dissolves share stake in Pfizer- SEC filing ‍

* Paulson & Co Inc raises share stake in Valeant Pharmaceuticals by 12.5 percent to 21.8 million shares ‍

* ‍Paulson & Co - Change in holdings are as of June 30, 2017 and compared with the previous quarter ended as of March 31, 2017 Source text for quarter ended June 30, 2017: (https://bit.ly/2w7Q27x) Source text for quarter ended March 31, 2017 (https://bit.ly/2pQh38R)


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities